Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

How the motor system integrates with working memory.

Marvel CL, Morgan OP, Kronemer SI.

Neurosci Biobehav Rev. 2019 Jul;102:184-194. doi: 10.1016/j.neubiorev.2019.04.017. Epub 2019 Apr 27. Review.

PMID:
31039359
2.

Can patients with cerebellar disease switch learning mechanisms to reduce their adaptation deficits?

Wong AL, Marvel CL, Taylor JA, Krakauer JW.

Brain. 2019 Mar 1;142(3):662-673. doi: 10.1093/brain/awy334.

PMID:
30689760
3.

Onset and Remission of Psychosis in Parkinson's Disease: Pharmacologic and Motoric Markers.

Hinkle JT, Perepezko K, Bakker CC, Broen MPG, Chin K, Dawson TM, Johnson V, Mari Z, Marvel CL, Mills KA, Pantelyat A, Pletnikova O, Rosenthal LS, Shepard MD, Stevens DA, Troncoso JC, Wang J, Pontone GM.

Mov Disord Clin Pract. 2018 Jan-Feb;5(1):31-38. doi: 10.1002/mdc3.12550. Epub 2017 Sep 15.

4.

Internal grant review to increase grant funding for junior investigators.

Thomas HS, Brodsky MB, Ewen JB, Bergey GK, Lloyd TE, Haughey NJ, Marvel CL.

Ann Neurol. 2017 Oct;82(4):497-502. doi: 10.1002/ana.25040. Epub 2017 Oct 4. No abstract available.

5.

Domain-specific cognitive impairment in non-demented Parkinson's disease psychosis.

Hinkle JT, Perepezko K, Bakker CC, Dawson TM, Johnson V, Mari Z, Marvel CL, Mills KA, Pantelyat A, Pletnikova O, Rosenthal LS, Shepard MD, Stevens DA, Troncoso JC, Wang J, Pontone GM.

Int J Geriatr Psychiatry. 2018 Jan;33(1):e131-e139. doi: 10.1002/gps.4736. Epub 2017 May 16.

6.

Impairments of Motor Function While Multitasking in HIV.

Kronemer SI, Mandel JA, Sacktor NC, Marvel CL.

Front Hum Neurosci. 2017 Apr 28;11:212. doi: 10.3389/fnhum.2017.00212. eCollection 2017.

7.

Reward, attention, and HIV-related risk in HIV+ individuals.

Anderson BA, Kronemer SI, Rilee JJ, Sacktor N, Marvel CL.

Neurobiol Dis. 2016 Aug;92(Pt B):157-65. doi: 10.1016/j.nbd.2015.10.018. Epub 2015 Oct 17.

8.

Motor system contributions to verbal and non-verbal working memory.

Liao DA, Kronemer SI, Yau JM, Desmond JE, Marvel CL.

Front Hum Neurosci. 2014 Sep 24;8:753. doi: 10.3389/fnhum.2014.00753. eCollection 2014.

9.

Attentional bias for nondrug reward is magnified in addiction.

Anderson BA, Faulkner ML, Rilee JJ, Yantis S, Marvel CL.

Exp Clin Psychopharmacol. 2013 Dec;21(6):499-506. doi: 10.1037/a0034575. Epub 2013 Oct 14.

10.

An fMRI investigation of cerebellar function during verbal working memory in methadone maintenance patients.

Marvel CL, Faulkner ML, Strain EC, Mintzer MZ, Desmond JE.

Cerebellum. 2012 Mar;11(1):300-10. doi: 10.1007/s12311-011-0311-0.

11.

From storage to manipulation: How the neural correlates of verbal working memory reflect varying demands on inner speech.

Marvel CL, Desmond JE.

Brain Lang. 2012 Jan;120(1):42-51. doi: 10.1016/j.bandl.2011.08.005. Epub 2011 Sep 1.

12.

Functional topography of the cerebellum in verbal working memory.

Marvel CL, Desmond JE.

Neuropsychol Rev. 2010 Sep;20(3):271-9. doi: 10.1007/s11065-010-9137-7. Epub 2010 Jun 22. Review.

13.

The contributions of cerebro-cerebellar circuitry to executive verbal working memory.

Marvel CL, Desmond JE.

Cortex. 2010 Jul-Aug;46(7):880-95. doi: 10.1016/j.cortex.2009.08.017. Epub 2009 Sep 9.

14.

The neural correlates of implicit sequence learning in schizophrenia.

Marvel CL, Turner BM, O'Leary DS, Johnson HJ, Pierson RK, Ponto LL, Andreasen NC.

Neuropsychology. 2007 Nov;21(6):761-77.

15.

The cerebellum and emotional experience.

Turner BM, Paradiso S, Marvel CL, Pierson R, Boles Ponto LL, Hichwa RD, Robinson RG.

Neuropsychologia. 2007 Mar 25;45(6):1331-41. Epub 2006 Nov 22.

16.

Configural processing in face recognition in schizophrenia.

Schwartz BL, Marvel CL, Drapalski A, Rosse RB, Deutsch SI.

Cogn Neuropsychiatry. 2002 Feb;7(1):15-39.

17.

Implicit learning of non-spatial sequences in schizophrenia.

Marvel CL, Schwartz BL, Howard DV, Howard JH Jr.

J Int Neuropsychol Soc. 2005 Oct;11(6):659-67.

18.

A quantitative measure of postural sway deficits in schizophrenia.

Marvel CL, Schwartz BL, Rosse RB.

Schizophr Res. 2004 Jun 1;68(2-3):363-72.

PMID:
15099618
19.

Cognitive and neurological impairment in mood disorders.

Marvel CL, Paradiso S.

Psychiatr Clin North Am. 2004 Mar;27(1):19-36, vii-viii. Review.

20.

Word production deficits in schizophrenia.

Marvel CL, Schwartz BL, Isaacs KL.

Brain Lang. 2004 Apr;89(1):182-91.

PMID:
15010249
21.

Adjuvant topiramate administration: a pharmacologic strategy for addressing NMDA receptor hypofunction in schizophrenia.

Deutsch SI, Schwartz BL, Rosse RB, Mastropaolo J, Marvel CL, Drapalski AL.

Clin Neuropharmacol. 2003 Jul-Aug;26(4):199-206.

PMID:
12897641
22.

Topiramate improves deficit symptoms in a patient with schizophrenia when added to a stable regimen of antipsychotic medication.

Drapalski AL, Rosse RB, Peebles RR, Schwartz BL, Marvel CL, Deutsch SI.

Clin Neuropharmacol. 2001 Sep-Oct;24(5):290-4.

PMID:
11586114
23.

Activation of NMDA receptors in the suprachiasmatic nucleus produces light-like phase shifts of the circadian clock in vivo.

Mintz EM, Marvel CL, Gillespie CF, Price KM, Albers HE.

J Neurosci. 1999 Jun 15;19(12):5124-30.

24.

Tetrodotoxin blocks NPY-induced but not muscimol-induced phase advances of wheel-running activity in Syrian hamsters.

Huhman KL, Marvel CL, Gillespie CF, Mintz EM, Albers HE.

Brain Res. 1997 Oct 24;772(1-2):176-80.

PMID:
9406970
25.

Serotonergic regulation of circadian rhythms in Syrian hamsters.

Mintz EM, Gillespie CF, Marvel CL, Huhman KL, Albers HE.

Neuroscience. 1997 Jul;79(2):563-9.

PMID:
9200739
26.

GABA(A) and GABA(B) agonists and antagonists alter the phase-shifting effects of light when microinjected into the suprachiasmatic region.

Gillespie CF, Mintz EM, Marvel CL, Huhman KL, Albers HE.

Brain Res. 1997 Jun 13;759(2):181-9.

PMID:
9221935
27.

Peptidergic mechanisms of action in the suprachiasmatic nucleus.

Huhman KL, Gillespie CF, Marvel CL, Albers HE.

Ann N Y Acad Sci. 1997 Apr 24;814:300-4. Review. No abstract available.

PMID:
9160982
28.

Neuropeptide Y phase shifts circadian rhythms in vivo via a Y2 receptor.

Huhman KL, Gillespie CF, Marvel CL, Albers HE.

Neuroreport. 1996 May 17;7(7):1249-52.

PMID:
8817542

Supplemental Content

Loading ...
Support Center